http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2727042-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e142317d9c9d744019d1683a6cc74d2a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-008
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
filingDate 2020-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2020-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83fbdf7ee39d68e517918cd47f5fe3d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79e2fb77b56a86896ef87b22c0a895f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0674b9c8e44ca3b400ebc24cc4794993
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33266a856e77a5ad4e4b1674c61bc87e
publicationDate 2020-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2727042-C1
titleOfInvention Method of treating peripheral corneal ectasia (versions)
abstract FIELD: medicine. n SUBSTANCE: group of inventions refers to medicine, namely to ophthalmology, and aims at treating peripheral corneal ectasia. Intrastromal ring tunnel is formed by femtosecond laser and donor tissue is implanted therein. According to the first version, the tunnel is formed at depth of 80 % of the minimum thickness of the cornea with an external diameter of 9.0 mm and an inner diameter of 3.0 mm. Tunnel formation is completed by performing radial incisions of the cornea in the strong meridian crossing the tunnel. Then mechanically, radial incisions are followed by corneal dissection through the tunnel and thinning area toward the limb, thus forming an intra-stromal pocket within the cornea thinning zone. Created pocket is implanted with a refractive donor's lenticule obtained from the other patient in a SMILE procedure for myopia, pre-colored and cut off at the poles or a segment of the ring of donor tissue produced by means of a femtosecond laser or cut out manually. Thereafter, one intrastromal corneal segment is implanted in the tunnel with an arc length of 80 to 359 degrees, or two intrastromal corneal segments with an arc length varying from 80 to 160 degrees each, placing them in the tunnel diametrically opposite to each other. According to the second version, the tunnel is formed at depth of 80 % of the minimum thickness of the cornea, with an external diameter of 9.0 mm and an inner diameter of 3.0 mm. formation of the tunnel is completed by performing radial incisions of the cornea in the strong meridian crossing the tunnel. Refractive donor lenticule, obtained from the other patient in SMILE procedure for myopia, pre-colored and cut off at the poles or segment of the ring of donor tissue, produced by means of a femtosecond laser or cut out manually, is implanted into the tunnel into the thinning area. Thereafter, one intrastromal corneal segment is implanted into the tunnel under the lenticule or donor tissue with arc length varying from 80 to 359 degrees, or two intrastromal corneal segments with arc length varying from 80 to 160 degrees, diametrically opposite to each other. At that, as per the first version, and according to the second version the stages of operations are completed without suturing or with application of single corneal sutures on radial incisions. After 3–6 months, cross-linking of the cornea is performed. n EFFECT: group of inventions makes it possible to increase accuracy and predictability of refractive result and, as a result, to improve visual functions of patients, to stop the progressing of corneal ectasia, and also to increase availability of donor material. n 2 cl, 10 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2773134-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2750902-C1
priorityDate 2020-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2684472-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2694517-C1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID410087
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426131764
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7048776
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6296
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449097368
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448241444

Total number of triples: 28.